In the majority of tumor cells, apoptotic pathways are dormant owing to the low expression of pro-apoptotic factors, such as pro-apoptotic members of Bcl-2 family proteins [3, 4], or glycolytic shift, described by Otto Warburg, which stimulates glycolysis in tumor cells and silences mitochondria [5, 6]. Here, BCL2 is linked to neoplasm.